Embecta ROA 2021-2024 | EMBC

Current and historical return on assets (ROA) values for Embecta (EMBC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Embecta ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-12-31 $0.06B $1.15B 4.81%
2024-09-30 $0.08B $1.29B 6.36%
2024-06-30 $0.07B $1.27B 5.71%
2024-03-31 $0.07B $1.20B 5.73%
2023-12-31 $0.06B $1.22B 4.50%
2023-09-30 $0.07B $1.21B 5.75%
2023-06-30 $0.05B $1.25B 3.96%
2023-03-31 $0.09B $1.21B 8.28%
2022-12-31 $0.16B $1.20B 15.36%
2022-09-30 $0.22B $1.09B 24.15%
2022-06-30 $0.34B $1.05B 39.62%
2022-03-31 $0.38B $0.83B 64.52%
2021-12-31 $0.41B $0.74B 107.07%
2021-09-30 $0.42B $0.79B 210.66%
Sector Industry Market Cap Revenue
Medical Medical Services $0.724B $1.123B
Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.273B 26.50
Elevance Health (ELV) United States $94.057B 12.14
CVS Health (CVS) United States $84.883B 10.55
Cencora (COR) United States $56.618B 20.55
Natera (NTRA) United States $21.276B 0.00
DiDi Global (DIDIY) China $19.908B 30.21
BioMerieux (BMXMF) France $15.658B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.897B 0.00
Solventum (SOLV) United States $11.572B 10.79
ICON (ICLR) Ireland $11.550B 10.74
CochLear (CHEOY) Australia $11.542B 0.00
Revvity (RVTY) United States $11.153B 18.83
Doximity (DOCS) United States $11.088B 57.66
Viatris (VTRS) United States $10.187B 3.24
Medpace Holdings (MEDP) United States $8.637B 22.94
Avantor (AVTR) United States $8.606B 12.51
Sonic Healthcare (SKHHY) Australia $8.191B 0.00
HealthEquity (HQY) United States $7.908B 38.90
Charles River Laboratories (CRL) United States $5.866B 11.57
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.018B 23.69
BrightSpring Health Services (BTSG) United States $3.685B 34.11
Sotera Health (SHC) United States $3.667B 20.84
Alignment Healthcare (ALHC) United States $3.063B 0.00
Surgery Partners (SGRY) United States $3.009B 34.51
Concentras Parent (CON) United States $2.767B 14.39
Organon (OGN) United States $2.267B 2.41
Progyny (PGNY) United States $2.005B 44.15
Ardent Health Partners (ARDT) United States $1.880B 0.00
Premier (PINC) United States $1.873B 11.99
GeneDx Holdings (WGS) United States $1.857B 72.70
GoodRx Holdings (GDRX) United States $1.799B 39.08
Agilon Health (AGL) United States $1.702B 0.00
PACS (PACS) United States $1.536B 0.00
Teladoc Health (TDOC) United States $1.254B 0.00
Pediatrix Medical (MD) United States $1.111B 9.32
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
Establishment Labs Holdings (ESTA) $0.967B 0.00
CareDx (CDNA) United States $0.845B 13.19
AMN Healthcare Services Inc (AMN) United States $0.759B 6.01
Nutex Health (NUTX) United States $0.720B 14.10
QDM (QDMI) Hong Kong, SAR China $0.583B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 13.67
Sonida Senior Living (SNDA) United States $0.447B 0.00
Enhabit (EHAB) United States $0.404B 37.95
InnovAge Holding (INNV) United States $0.391B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.375B 0.00
LifeMD (LFMD) United States $0.332B 0.00
SBC Medicals (SBC) United States $0.320B 0.00
DocGo (DCGO) United States $0.240B 9.79
Oncology Institute (TOI) United States $0.200B 0.00
Performant Healthcare (PHLT) United States $0.186B 0.00
Beauty Health (SKIN) United States $0.133B 0.00
Sera Prognostics (SERA) United States $0.105B 0.00
Ascend Wellness Holdings (AAWH) United States $0.090B 0.00
So-Young (SY) China $0.085B 0.00
OncoCyte (OCX) United States $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.078B 0.00
Biodesix (BDSX) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Pheton Holdings (PTHL) China $0.025B 0.00
ModivCare (MODV) United States $0.020B 7.05
KindlyMD (KDLY) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00